[1] Colloca L, Ludman T, Bouhassira D, et al.Neuropathic pain[J]. Nat Rev Dis Primers, 2017, 3: 17002. [2] Alles SRA, Smith PA.Etiology and Pharmacology of Neuropathic Pain[J]. Pharmacol Rev, 2018, 70(2): 315-347. [3] St John Smith E. Advances in understanding nociception and neuropathic pain[J]. J Neurol, 2018, 265(2): 231-238. [4] Chu LW, Cheng KI, Chen JY, et al.Loganin prevents chronic constriction injury-provoked neuropathic pain by reducing TNF-α/IL-1β-mediated NF-κB activation and Schwann cell demyelination[J]. Phytomedicine. 2020, 67: 153166. [5] Yi MH, Liu YU, Liu K, et al.Chemogenetic manipulation of microglia inhibits neuroinflammation and neuropathic pain in mice[J]. Brain Behav Immun, 2021, 92: 78-89. [6] Zhen Y, Zhang H.NLRP3 Inflammasome and Inflammatory Bowel Disease[J]. Front Immunol, 2019, 10: 276. [7] Mridha AR, Wree A, Robertson AAB, et al.NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice[J]. J Hepatol, 2017, 66(5): 1037-1046. [8] Zhou J, Wang L, Wang J, et al.Paeoniflorin and Albiflorin Attenuate Neuropathic Pain via MAPK Pathway in Chronic Constriction Injury Rats[J]. Evid Based Complement Alternat Med, 2016, 2016: 1-11. [9] Bennett GJ, Xie YK.A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man[J]. Pain, 1988, 33(1): 87-107. [10] Zhou Y, Tong Z, Jiang S, et al.The Roles of Endoplasmic Reticulum in NLRP3 Inflammasome Activation[J]. Cells, 2020, 9(5): 1219. [11] Kelley N, Jeltema D, Duan Y, et al.The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation[J]. Int J Mol Sci, 2019, 20(13): 3328. [12] He Y, Hara H, Núñez G.Mechanism and Regulation of NLRP3 Inflammasome Activation[J]. Trends Biochem Sci, 2016, 41(12): 1012-1021. [13] Biasizzo M, Kopitar-Jerala N.Interplay Between NLRP3 Inflammasome and Autophagy[J]. Front Immunol, 2020, 11: 591803. [14] Zahid A, Li B, Kombe AJK, et al.Pharmacological Inhibitors of the NLRP3 Inflammasome[J]. Front Immunol, 2019, 10: 2538. [15] He W, Long T, Pan Q, et al.Microglial NLRP3 inflammasome activation mediates IL-1β release and contributes to central sensitization in a recurrent nitroglycerin-induced migraine model[J]. J Neuroinflammation, 2019, 16(1): 78. |